- Home
- DAIO vs ANVS Comparison
DAIO vs ANVS Comparison
Compare DAIO & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAIO
- ANVS
- Stock Information
- Founded
- DAIO 1969
- ANVS 2008
- Country
- DAIO United States
- ANVS United States
- Employees
- DAIO N/A
- ANVS N/A
- Industry
- DAIO Electrical Products
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- DAIO Industrials
- ANVS Health Care
- Exchange
- DAIO Nasdaq
- ANVS Nasdaq
- Market Cap
- DAIO 22.0M
- ANVS 24.2M
- IPO Year
- DAIO N/A
- ANVS 2020
- Fundamental
- Price
- DAIO $2.49
- ANVS $1.69
- Analyst Decision
- DAIO Strong Buy
- ANVS Strong Buy
- Analyst Count
- DAIO 1
- ANVS 4
- Target Price
- DAIO $4.00
- ANVS $40.67
- AVG Volume (30 Days)
- DAIO 37.3K
- ANVS 507.4K
- Earning Date
- DAIO 04-24-2025
- ANVS 05-13-2025
- Dividend Yield
- DAIO N/A
- ANVS N/A
- EPS Growth
- DAIO N/A
- ANVS N/A
- EPS
- DAIO N/A
- ANVS N/A
- Revenue
- DAIO $21,846,000.00
- ANVS N/A
- Revenue This Year
- DAIO $4.81
- ANVS N/A
- Revenue Next Year
- DAIO N/A
- ANVS N/A
- P/E Ratio
- DAIO N/A
- ANVS N/A
- Revenue Growth
- DAIO N/A
- ANVS N/A
- 52 Week Low
- DAIO $1.88
- ANVS $1.11
- 52 Week High
- DAIO $3.14
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- DAIO 61.01
- ANVS 56.79
- Support Level
- DAIO $2.43
- ANVS $1.48
- Resistance Level
- DAIO $2.63
- ANVS $1.74
- Average True Range (ATR)
- DAIO 0.14
- ANVS 0.18
- MACD
- DAIO 0.04
- ANVS 0.04
- Stochastic Oscillator
- DAIO 70.83
- ANVS 45.83
About DAIO Data I/O Corporation
Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.